The movement of viral vectors, cell therapies and other antibody-based next-generation drug products toward commercialization is driving the need for new and different technologies and facilities. These facilities need to be more flexible and suited for multiproduct manufacturing. Large stainless steel tanks will remain part of the solution, but single-use systems for upstream and downstream operations are increasingly important.
To read more go to https://www.pharmasalmanac.com/articles/design-of-complex-biopharmaceutical-facilities-considering-option-and-alternatives
